English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/122961
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Heteromers of amyloid precursor protein in cerebrospinal fluid

AuthorsCuchillo-Ibáñez, Inmaculada; López-Font, Inmaculada; Boix-Amorós, Alba; Brinkmalm, Gunnar; Blennow, Kaj; Molinuevo, José L.; Sáez-Valero, Javier
KeywordssAPPα
sAPPβ
Heteromers
Cerebrospinal fluid
Alzheimer’s disease
ELISA
Issue Date8-Jan-2015
PublisherBioMed Central
CitationMolecular Neurodegeneration 10(2): 1-11(2015)
AbstractBackground: Soluble fragments of the amyloid precursor protein (APP) generated by α- and β-secretases, sAPPα and sAPPβ, have been postulated as promising new cerebrospinal fluid (CSF) biomarkers for the clinical diagnosis of Alzheimer’s disease (AD). However, the capacity of these soluble proteins to assemble has not been explored and could be relevant. Our aim is to characterize possible sAPP oligomers that could contribute to the quantification of sAPPα and sAPPβ in CSF by ELISA, as well as to characterize the possible presence of soluble full-length APP (sAPPf).
Results: We employed co-immunoprecipitation, native polyacrylamide gel electrophoresis and ultracentrifugation in sucrose density gradients to characterize sAPP oligomers in CSF. We have characterized the presence of sAPPf in CSF from NDC and AD subjects and demonstrated that all forms, including sAPPα and sAPPβ, are capable of assembling into heteromers, which differ from brain APP membrane-dimers. We measured sAPPf, sAPPα and sAPPβ by ELISA in CSF samples from AD (n = 13) and non-disease subjects (NDC, n = 13) before and after immunoprecipitation with antibodies against the C-terminal APP or against sAPPβ. We demonstrated that these sAPP heteromers participate in the quantification of sAPPα and sAPPβ by ELISA. Immunoprecipitation with a C-terminal antibody to remove sAPPf reduced by ~30% the determinations of sAPPα and sAPPβ by ELISA, whereas immunoprecipitation with an APPβ antibody reduced by ~80% the determination of sAPPf and sAPPα.
Conclusions: The presence of sAPPf and sAPP heteromers should be taken into consideration when exploring the levels of sAPPα and sAPPβ as potential CSF biomarkers.
Publisher version (URL)http://dx.doi.org/10.1186/1750-1326-10-2
URIhttp://hdl.handle.net/10261/122961
DOI10.1186/1750-1326-10-2
ISSN1750-1326
Appears in Collections:(IN) Artículos
Files in This Item:
File Description SizeFormat 
Heteromers_amyloid_CuchilloIbañez.pdf1,2 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.